Metachronous Pancreatic Metastasis from Rectal Cancer that Masqueraded as a Primary Pancreatic Cancer: A Rare and Difficult-to-Diagnose Metastatic Tumor in the Pancreas.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
30 Nov 2019
30 Nov 2019
Historique:
entrez:
1
12
2019
pubmed:
1
12
2019
medline:
25
4
2020
Statut:
epublish
Résumé
BACKGROUND Pancreatic metastasis from colorectal cancer is rare and can masquerade as primary pancreatic cancer. CASE REPORT A 70-year-old male was diagnosed with advanced rectal cancer with multiple liver metastases. After neoadjuvant chemotherapy, he underwent radical surgery for the primary tumor and hepatectomy for multiple liver metastases. Adjuvant chemotherapies and additional surgeries were subsequently required for recurrences in the liver, lung, and lymph nodes. A diffuse hypovascular nodule in the pancreatic head and a solitary liver metastasis were detected 2.5 years after the initial surgery and he accordingly underwent further chemotherapy. However, the pancreatic tumor progressed, invading the pancreatic duct and biliary tract. Obstructive jaundice finally prompted discontinuation of chemotherapy and he underwent biliary drainage. His diffuse and hypovascular tumor was clinically and radiographically diagnosed as a primary pancreatic cancer. Pancreatic resection for the pancreatic tumor and hepatectomy for the liver metastasis were performed 4.2 years after the initial surgery, achieving radiographic and surgical curative resection. Pathological examination of the surgical specimen resulted in a definitive diagnosis of metachronous pancreatic metastasis from his primary rectal cancer. Despite further chemotherapy, his general condition worsened; however, he remains alive 5.4 years after the initial surgery, with best supportive care. CONCLUSIONS Pancreatic metastasis originating from rectal cancer can masquerade as primary pancreatic cancer clinically and radiologically. Multimodality treatment is mandatory for metastatic colorectal cancer. Aggressive surgeries for pancreatic metastasis should be considered if curative resection appears possible radiographically and/or intraoperatively.
Identifiants
pubmed: 31784503
pii: 918669
doi: 10.12659/AJCR.918669
pmc: PMC6910167
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1781-1787Références
Indian J Surg Oncol. 2019 Jun;10(2):251-257
pubmed: 31168244
Gan To Kagaku Ryoho. 2019 Feb;46(2):327-329
pubmed: 30914549
Gan To Kagaku Ryoho. 2016 Nov;43(12):2468-2470
pubmed: 28133357
J Korean Surg Soc. 2011 Apr;80(4):278-82
pubmed: 22066048
World J Surg Oncol. 2010 Apr 07;8:26
pubmed: 20374636
Am J Case Rep. 2019 Apr 22;20:567-574
pubmed: 31006768
J Hepatobiliary Pancreat Surg. 2007;14(6):590-4
pubmed: 18040627
J Med Life. 2015;8 Spec Issue:12-4
pubmed: 26361505
Lancet. 2016 Jul 2;388(10039):73-85
pubmed: 26830752
Surg Case Rep. 2016 Dec;2(1):49
pubmed: 27225417
Case Rep Gastrointest Med. 2018 Dec 5;2018:6405125
pubmed: 30631609
J Coll Physicians Surg Pak. 2009 Apr;19(4):223-7
pubmed: 19356336
JOP. 2007 Mar 10;8(2):214-22
pubmed: 17356246
Lancet Oncol. 2009 Mar;10(3):287-93
pubmed: 19261257
Ann Surg Oncol. 2019 Jun;26(6):1649-1656
pubmed: 30924017
Intern Med. 2017;56(3):301-305
pubmed: 28154274
Gastroenterol Clin Biol. 2008 Mar;32(3):258-60
pubmed: 18456107
J Anus Rectum Colon. 2019 Oct 30;3(4):175-195
pubmed: 31768468
Dis Colon Rectum. 2009 Jun;52(6):1154-9
pubmed: 19581861